The ASSOCIATE study investigators have reported that the I f current inhibitor, ivabradine, is safe, improves exercise performance, and delays the development of ischemia in patients with chronic ...

A recent state-of-the-art review overlooks a “safe and effective” therapy for patients with stable angina and no good treatment options, according to several cardiologists. The coronary sinus reducer ...

This large-scale open clinical trial of a new modified-release formulation of trimetazidine was conducted by 241 cardiologists in 906 patients with stable angina. All patients were required to have ...

Thanks to results from the ORBITA-2 randomized trial, there are now two “evidence-based pathways” for the treatment of patients with stable angina, according to a newly published editorial. Harvey ...

Please provide your email address to receive an email when new articles are posted on . The study included data on 32,691 patients with stable CAD from the prospective, observational CLARIFY registry.

Angina is a type of chest pain produced by a decrease in blood flow to the heart. Angina is mostly an indication of coronary artery disease. Angina, commonly known as angina pectoris, produces ...

PHOENIX, AZ — Cardiologists commonly fail to recognize that an outpatient with stable CAD has had recent chest pain, so they do not escalate angina treatment, a study of more than 1000 outpatients ...

– The IMPROVE-ISCHEMIA Phase 2 clinical trial met the primary endpoint of tolerability and safety; 8-weeks treatment with ninerafaxstat also demonstrated a statistically significant improvement in ...

PARIS — Among a cohort of patients with stable CAD, angina yielded worse outcomes in patients with prior MI but did not make a difference in patients without prior MI, according to results from the ...